Aptamers for Targeting SARS-CoV-2 Proteins

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays.

Illustration of an Aptamer interacting with a target protein. Image credit: AMS Bio

Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a target. This target can be an organic molecule, free or carried in cells or tissues, or inorganic components, such as metal ions. Aptamers have generated significant interest as promising tools, that compete with monoclonal antibodies, for detection and inhibition of specific markers of human diseases because they offer high specificity for their target, no to low immunogenicity and easy in vitro selection.

To better understand the genetic architecture of host proteins interacting with SARS-CoV-2 or mediating host response to COVID-19 - using an aptamer-based technique can help to identify new or repurpose existing drugs targeting those proteins.

As aptamers bind targets with high selectivity and specificity, they are an ideal tool to help develop new approaches to early-stage diagnostic assay and adequate therapy. With AMSBIO aptamers targeting SARS-CoV-2 S1 protein, S2 protein, RBD protein or nucleocapsid protein, they can be used in wide range of detection methods and for development of COVID-19 diagnostic assays.

For further information on the new range of aptamers targeting SARS-CoV-2 proteins please visit https://www.amsbio.com/aptamers-for-infectious-diseases/ or contact AMSBIO on+44-1235-828200 / +1-617-945-5033 / [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2021, November 05). Aptamers for Targeting SARS-CoV-2 Proteins. AZoLifeSciences. Retrieved on June 25, 2022 from https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx.

  • MLA

    AMS Biotechnology. "Aptamers for Targeting SARS-CoV-2 Proteins". AZoLifeSciences. 25 June 2022. <https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx>.

  • Chicago

    AMS Biotechnology. "Aptamers for Targeting SARS-CoV-2 Proteins". AZoLifeSciences. https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx. (accessed June 25, 2022).

  • Harvard

    AMS Biotechnology. 2021. Aptamers for Targeting SARS-CoV-2 Proteins. AZoLifeSciences, viewed 25 June 2022, https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post
You might also like...
Latest tools for COVID-19 Omicron variant research